2758 related articles for article (PubMed ID: 7992101)
1. Photodynamic therapy in dermatology with porfimer sodium and benzoporphyrin derivative: an update.
Lui H
Semin Oncol; 1994 Dec; 21(6 Suppl 15):11-4. PubMed ID: 7992101
[TBL] [Abstract][Full Text] [Related]
2. Photosensitizers in photodynamic therapy.
Levy JG
Semin Oncol; 1994 Dec; 21(6 Suppl 15):4-10. PubMed ID: 7992105
[TBL] [Abstract][Full Text] [Related]
3. The use of photodynamic therapy in bone marrow purging.
Mulroney CM; Glück S; Ho AD
Semin Oncol; 1994 Dec; 21(6 Suppl 15):24-7. PubMed ID: 7992104
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy of lung cancer.
Lam S
Semin Oncol; 1994 Dec; 21(6 Suppl 15):15-9. PubMed ID: 7992102
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy and cancer of the esophagus.
Marcon NE
Semin Oncol; 1994 Dec; 21(6 Suppl 15):20-3. PubMed ID: 7992103
[TBL] [Abstract][Full Text] [Related]
6. A photodynamic therapy combined with topical 5-aminolevulinic acid and systemic hematoporphyrin derivative is more efficient but less phototoxic for cancer.
Wang Y; Lin Y; Zhang HG; Zhu J
J Cancer Res Clin Oncol; 2016 Apr; 142(4):813-21. PubMed ID: 26581214
[TBL] [Abstract][Full Text] [Related]
7. Comparative skin phototoxicity in mice with two photosensitizing drugs: benzoporphyrin derivative monoacid ring A and porfimer sodium (Photofrin).
Wolford ST; Novicki DL; Kelly B
Fundam Appl Toxicol; 1995 Jan; 24(1):52-6. PubMed ID: 7713343
[TBL] [Abstract][Full Text] [Related]
8. Mono-L-aspartyl chlorin e6 (NPe6) and hematoporphyrin derivative (HpD) in photodynamic therapy administered to a human cholangiocarcinoma model.
Wong Kee Song LM; Wang KK; Zinsmeister AR
Cancer; 1998 Jan; 82(2):421-7. PubMed ID: 9445202
[TBL] [Abstract][Full Text] [Related]
9. [History of photodynamic therapy--past, present and future].
Kato H
Gan To Kagaku Ryoho; 1996 Jan; 23(1):8-15. PubMed ID: 8546474
[TBL] [Abstract][Full Text] [Related]
10. A novel ATX-S10(Na) photodynamic therapy for human skin tumors and benign hyperproliferative skin.
Takahashi H; Itoh Y; Nakajima S; Sakata I; Iizuka H
Photodermatol Photoimmunol Photomed; 2004 Oct; 20(5):257-65. PubMed ID: 15379877
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy for the treatment of squamous cell carcinoma using benzoporphyrin derivative.
Marcus J; Glassberg E; Dimino-Emme L; Yamamoto R; Moy RL; Vari SG; Papaioannou T; Pergadia VR; Snyder WJ; Grundfest WS
J Dermatol Surg Oncol; 1994 Jun; 20(6):375-82. PubMed ID: 8014262
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy with systemic administration of photosensitizers in dermatology.
Calzavara-Pinton PG; Szeimies RM; Ortel B; Zane C
J Photochem Photobiol B; 1996 Nov; 36(2):225-31. PubMed ID: 9002266
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy in dermatology: recent developments.
Lui H; Anderson RR
Dermatol Clin; 1993 Jan; 11(1):1-13. PubMed ID: 8435904
[TBL] [Abstract][Full Text] [Related]
14. Effects of photodynamic therapy on adhesion molecules and metastasis.
Rousset N; Vonarx V; Eléouet S; Carré J; Kerninon E; Lajat Y; Patrice T
J Photochem Photobiol B; 1999; 52(1-3):65-73. PubMed ID: 10643074
[TBL] [Abstract][Full Text] [Related]
15. Long-term survival of patients treated with photodynamic therapy for carcinoma in situ and early non-small-cell lung carcinoma.
Corti L; Toniolo L; Boso C; Colaut F; Fiore D; Muzzio PC; Koukourakis MI; Mazzarotto R; Pignataro M; Loreggian L; Sotti G
Lasers Surg Med; 2007 Jun; 39(5):394-402. PubMed ID: 17565719
[TBL] [Abstract][Full Text] [Related]
16. Photodynamic therapy of squamous cell carcinoma. An evaluation of a new photosensitizing agent, benzoporphyrin derivative and new photoimmunoconjugate.
Hemming AW; Davis NL; Dubois B; Quenville NF; Finley RJ
Surg Oncol; 1993; 2(3):187-96. PubMed ID: 8252208
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy using new photosensitizer shows promise for skin tumor treatment and possibility for psoriasis treatment.
Coulter AH
J Clin Laser Med Surg; 1993 Jun; 11(3):149-50. PubMed ID: 10146272
[No Abstract] [Full Text] [Related]
18. A dose ranging study of photodynamic therapy with porfimer sodium (Photofrin) for treatment of basal cell carcinoma.
Oseroff AR; Blumenson LR; Wilson BD; Mang TS; Bellnier DA; Parsons JC; Frawley N; Cooper M; Zeitouni N; Dougherty TJ
Lasers Surg Med; 2006 Jun; 38(5):417-26. PubMed ID: 16788928
[TBL] [Abstract][Full Text] [Related]
19. Analysis of acute vascular damage after photodynamic therapy using benzoporphyrin derivative (BPD).
Fingar VH; Kik PK; Haydon PS; Cerrito PB; Tseng M; Abang E; Wieman TJ
Br J Cancer; 1999 Apr; 79(11-12):1702-8. PubMed ID: 10206280
[TBL] [Abstract][Full Text] [Related]
20. [Selective hematoporphyrin derivative (HMD) application in arterial vessels using a porous balloon catheter results in equivalent levels as compared to high-dose systemic administration].
Gonschior P; Erdemci A; Gerheuser F; Gonschior GM; Mack B; Kolbe T; Goetz AE; Höfling B
Z Kardiol; 1991 Dec; 80(12):738-45. PubMed ID: 1837968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
